Soluble tumor necrosis factor receptors in chronic hepatitis C:: a correlation with histological fibrosis and activity

被引:161
作者
Zylberberg, H
Rimaniol, AC
Pol, S
Masson, A
De Groote, D
Berthelot, P
Bach, JF
Bréchot, C
Zavala, F
机构
[1] Hop Necker Enfants Malad, Hepatol Unit, F-75015 Paris, France
[2] Hop Necker Enfants Malad, INSERM, U25, Paris, France
[3] Hop Necker Enfants Malad, INSERM, U370, Paris, France
[4] Hybridotest Inst Pasteur, Paris, France
[5] Biosource Europe SA, Zoning Ind, Fleurus, Belgium
关键词
hepatitis C virus; liver biopsy; tumor necrosis factor; tumor necrosis factor receptors;
D O I
10.1016/S0168-8278(99)80060-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Tumor necrosis factor-alpha (TNF) is a mediator of inflammation and cellular immune response. Soluble TNF receptors (sTNFR) sTNF-R55 and sTNF-R75, which compete with cellular receptors for the binding of TNF, have been detected at high levels in infectious diseases including human immunodeficiency virus and HBV infection. In order to investigate the activation of the TNF system in HCV infection, we have analyzed the balance between TNF and sTNF-R in 60 HCV-infected subjects according to their clinical, biological, virological and histological characteristics. Methods: Serum TNF, sTNF-R55 and sTNF-R75 levels were determined by ELISA before any therapy and were compared to a control group of 60 healthy subjects and a group of 34 HBV-infected patients. Results: Mean TNF levels were 50.5+/-4.5 pg/ml in HCV patients, and undetectable (<5 pg/ml) in the control subjects. sTNF-R55 and sTNF-R75 levels were significantly higher in HCV-infected patients than in the controls: 2.88+/-0.14 ng/ml vs 1.30+/-0.05, (p=0.0001), and 9.54+/-0.58 ng/ml vs 4.19+/-016, (p=0.0001), respectively, sTNF-R55 and TNF-alpha levels in HCV patients were not significantly different from levels in HBV patients. sTNF-R75 levels were slightly lower than in HBV patients (9.54+/-0.58 vs 11.4+/-0.79 ng/ml, p=0.03). In contrast to other infectious diseases, there was no correlation between levels of sTNF-R and TNF. sTNF-R75 but not TNF levels were correlated with aminotransferases levels (p=0.0001 and p=0.0015 for aspartate and alanine aminotransferase, respectively), while sTNF-R55 levels were significantly correlated only with aspartate aminotransferase levels (p=0.003). sTNF-R75 levels were significantly correlated with the Metavir activity index (p=0.01), and sTNF-R55 and sTNF-R75 levels were significantly higher in patients with vs. without cirrhosis (3.22+/-0.21 vs. 2.54+/-0.17 ng/ml (p<0.02) and 11.6+/-0.86 vs. 7.5+/-0.53 ng/ml (p<0.001), respectively). sTNF-R55, sTNF-R75 and TNF levels were not correlated with viral load, genotype or response to interferon therapy. Conclusions: Levels of soluble TNF receptors, and particularly sTNF-R75, are significantly correlated with the severity of the disease but not with virological parameters such as quantitative viremia and genotype. High TNF-R production could thus suggest that HCV-related liver disease involves immunological mechanisms, including activation of the TNF system.
引用
收藏
页码:185 / 191
页数:7
相关论文
共 35 条
[1]   CORRELATION BETWEEN SERUM LEVELS OF SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR AND DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ADERKA, D ;
WYSENBEEK, A ;
ENGELMANN, H ;
COPE, AP ;
BRENNAN, F ;
MOLAD, Y ;
HORNIK, V ;
LEVO, Y ;
MAINI, RN ;
FELDMANN, M ;
WALLACH, D .
ARTHRITIS AND RHEUMATISM, 1993, 36 (08) :1111-1120
[2]   SERUM LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) AND SOLUBLE TNF RECEPTORS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - CORRELATIONS TO CLINICAL, IMMUNOLOGICAL, AND VIROLOGICAL PARAMETERS [J].
AUKRUST, P ;
LIABAKK, NB ;
MULLER, F ;
LIEN, E ;
ESPEVIK, T ;
FROLAND, SS .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (02) :420-424
[3]   CACHECTIN (TUMOR NECROSIS FACTOR) - A MACROPHAGE HORMONE GOVERNING CELLULAR-METABOLISM AND INFLAMMATORY RESPONSE [J].
BEUTLER, B ;
CERAMI, A .
ENDOCRINE REVIEWS, 1988, 9 (01) :57-66
[4]   Soluble tumor necrosis factor-alpha receptor type II (sTNF alpha RII) correlates with human immunodeficiency virus (HIV) RNA copy number in HIV-infected patients [J].
Bilello, JA ;
Stellrecht, K ;
Drusano, GL ;
Stein, DS .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (02) :464-467
[5]   IDENTIFICATION OF 2 TYPES OF TUMOR-NECROSIS-FACTOR RECEPTORS ON HUMAN CELL-LINES BY MONOCLONAL-ANTIBODIES [J].
BROCKHAUS, M ;
SCHOENFELD, HJ ;
SCHLAEGER, EJ ;
HUNZIKER, W ;
LESSLAUER, W ;
LOETSCHER, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (08) :3127-3131
[6]  
Calvano SE, 1996, ARCH SURG-CHICAGO, V131, P434
[7]   INCREASED LEVELS OF SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS IN THE SERA AND SYNOVIAL-FLUID OF PATIENTS WITH RHEUMATIC DISEASES [J].
COPE, AP ;
ADERKA, D ;
DOHERTY, M ;
ENGELMANN, H ;
GIBBONS, D ;
JONES, AC ;
BRENNAN, FM ;
MAINI, RN ;
WALLACH, D ;
FELDMANN, M .
ARTHRITIS AND RHEUMATISM, 1992, 35 (10) :1160-1169
[8]  
DESCAMPSLATSCHA B, 1995, J IMMUNOL, V154, P882
[9]   EVIDENCE FOR DIFFERENT EFFECTS OF SOLUBLE TNF-RECEPTORS ON VARIOUS TNF MEASUREMENTS IN HUMAN BIOLOGICAL-FLUIDS [J].
ENGELBERTS, I ;
STEPHENS, S ;
FRANCOT, GJM ;
VANDERLINDEN, CJ ;
BUURMAN, WA .
LANCET, 1991, 338 (8765) :515-516
[10]  
ENGELMANN H, 1990, J BIOL CHEM, V265, P1531